The COVID-19 pandemic has greatly impacted the entire patient experience in interventional oncology at our institution. This goes beyond the known infected patients or those under investigation with the newly expected, necessary personal protective equipment (PPE) and safety precautions taken. It a
“Why are you bringing all these cancer patients into the hospital and putting us all at risk?” asked one of my non-IO colleagues. An undiagnosed COVID patient brought in that day for an extended procedure resulted in losing six staff to a week-long quarantine.
As we all struggle to provide optimal care for our patients during these unprecedented times, it is clear that the pandemic has affected us all in different ways: with differing timing, magnitude, resource constraints, and local policies.
Given these circumstances, it is difficult to develop broadl
The Society of Interventional Oncology NCCN Committee spearheaded an effort in 2019 to provide input into the 2020 update of Kidney Cancer NCCN guidelines. SIO brought our RCC task force together and helped us through the specifics of the NCCN submission process.
MSK Workshop Chair, Dr. Jack Jennings of Washington University Saint Louis, shares his perspective on SIO as he leads the SIO2020 Program Committee planning of the second annual Musculoskeletal Interventional Oncology Workshop at SIO2020.